Home › Asset managers › Compare 2025-2026 › American Century vs ProShares
American Century 2025-2026 · ProShares 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 26,123 | 24,929 | 1,050 | 144 | 96.0% | 95.7% |
| Board proposals | 23,824 | 22,789 | 917 | 118 | 96.1% | 95.9% |
| E&S shareholder proposals | 175 | 156 | 19 | 0 | 89.1% | 89.1% |
| Other items | 2,124 | 1,984 | 114 | 26 | 94.6% | 94.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,035 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | ProShares |
|---|---|---|---|---|---|---|
| 10X GENOMICS, INC. | June 4, 2026 | A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 10 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Approval of Amended 1982 Restricted Stock Award Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Approval of Amended Strategic Deployment Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| 4D MOLECULAR THERAPEUTICS, INC. | June 17, 2026 | Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers (''say-on-pay vote''). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| A-MARK PRECIOUS METALS, INC. | November 12, 2025 | Advisory vote on executive compensation Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| AAR CORP. | September 16, 2025 | Advisory proposal to approve our Fiscal Year 2025 executive compensation Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000. Compensation |
Board | For | AGAINST 1 fund |
FOR 5 funds |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 15 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 15 funds |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Approval of 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| ACCENDRA HEALTH, INC. | May 14, 2026 | Non-Binding advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| ACCENTURE PLC | January 28, 2026 | To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 20 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval, by non-binding advisory vote, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 10 funds |
| ACME UNITED CORPORATION | April 27, 2026 | Approval, by non-binding advisory vote, of the compensation of the named executive officers of the Company as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| ADAPTHEALTH CORP. | June 18, 2026 | Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| ADTALEM GLOBAL EDUCATION INC. | November 12, 2025 | Say-on-pay: Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| ADVANCED ENERGY INDUSTRIES, INC. | May 7, 2026 | Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; Compensation |
Board | For | FOR 6 funds |
AGAINST 16 funds |
| AEBI SCHMIDT HOLDING AG | May 21, 2026 | Election of Barend Fruithof as the Chair of the Board of Directors Corporate Governance |
Board | For | FOR 5 funds |
AGAINST 8 funds |
| AEHR TEST SYSTEMS | October 20, 2025 | Proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| AEROVIRONMENT, INC. | September 25, 2025 | Management proposal to approve the amendment and restatement of the company's 2021 equity incentive plan Compensation |
Board | For | AGAINST 2 funds |
FOR 17 funds |
| AES CORP | April 29, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 19 funds |
| AGILYSYS, INC. | September 4, 2025 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers set forth in the attached Proxy Statement Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To vote, on an advisory basis, to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| AIR LEASE CORPORATION | December 18, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of Air Lease Corporation in connection with the merger (the ''Compensation Proposal''). Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 10 funds |
AGAINST 22 funds |
| ALARM.COM HOLDINGS, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 14 funds |
| ALEXANDER & BALDWIN, INC. | March 9, 2026 | To consider and vote on a proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 15 funds |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 17 funds |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| ALLY FINANCIAL INC. | May 6, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 7 funds |
| ALPHA & OMEGA SEMICONDUCTOR LTD | November 12, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as described in the Proxy Statement Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 14 funds |
| ALPHABET INC. | June 5, 2026 | Advisory vote to approve compensation awarded to named executive officers Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 35 funds |
| ALPHATEC HOLDINGS, INC. | June 10, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Vote on Proposal to Approve the Company's Amended and Restated 2011 Stock Plan for Non-Employee Directors Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| AMENTUM HOLDINGS, INC | February 6, 2026 | Advisory vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| AMERESCO, INC. (AMRC) | June 4, 2026 | To approve on a non-binding advisory basis the compensation of our named executive officer as described in the Ameresco, Inc. Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| AMERICA'S CAR-MART, INC. | September 25, 2025 | To approve an advisory resolution regarding the Company's compensation of its named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| AMERICAN AIRLINES GROUP INC. | June 10, 2026 | A proposal to approve the Amended and Restated 2023 Incentive Award Plan Compensation |
Board | For | AGAINST 2 funds |
FOR 7 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 17 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | To approve the 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 17 funds |
| AMERICAN SUPERCONDUCTOR CORPORATION | July 25, 2025 | To approve, on an advisory basis, the compensation of AMSC's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| AMERICAN TOWER CORPORATION | May 20, 2026 | To approve the American Tower Corporation 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 18 funds |
| AMERICAN VANGUARD CORPORATION | July 2, 2025 | Resolved, that the compensation paid to the Company's named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby approved. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| AMERICAN WOODMARK CORPORATION | August 21, 2025 | To approve on an advisory basis the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 11 funds |
| AMERICAN WOODMARK CORPORATION | October 30, 2025 | To approve, on an advisory (non-binding) basis, the compensation that will or may be paid to American Woodmark's named executive officers in connection with the transactions contemplated by the merger agreement; and Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 13 funds |
| AMICUS THERAPEUTICS, INC. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 13 funds |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 17 funds |
| AMPLITUDE, INC. | June 9, 2026 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| ANGIODYNAMICS, INC. | November 10, 2025 | Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 15 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 15 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| ANNEXON, INC. | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 17 funds |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 18 funds |
| APOGEE ENTERPRISES, INC. | June 24, 2026 | APPROVAL OF THE APOGEE ENTERPRISES, INC. 2019 STOCK INCENTIVE PLAN, AS AMENDED AND RESTATED (2026) TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR AWARDS FROM 2,150,000 TO 2,950,000. Compensation |
Board | For | AGAINST 10 funds |
FOR 13 funds |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| APPFOLIO, INC. | June 12, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve the 2026 equity incentive plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| AQUESTIVE THERAPEUTICS, INC. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 12 funds |
| ARCBEST CORPORATION | April 24, 2026 | To approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions |
Board | For | FOR 10 funds |
AGAINST 12 funds |
| ARCTURUS THERAPEUTICS, HOLDINGS INC. | June 5, 2026 | Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 16 funds |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| ARDELYX, INC | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (''Say-on-Pay''); Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| ARLO TECHNOLOGIES, INC. | June 18, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 12 funds |
| ARM HOLDINGS PLC | September 9, 2025 | Approve Remuneration Report Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 11 funds |
| ARMOUR RESIDENTIAL REIT, INC. | April 30, 2026 | To approve ARMOUR's Fourth Amended and Restated 2009 Stock Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 12 funds |
| ARQ, INC. | June 10, 2026 | To approve the Arq, Inc. 2026 Omnibus Incentive Plan; and Compensation |
Board | For | FOR 2 funds |
AGAINST 9 funds |
| ARRAY TECHNOLOGIES, INC. | May 19, 2026 | Approval, on an advisory basis, of our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 15 funds |
| ARVINAS, INC. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| ASTRIA THERAPEUTICS, INC. | January 21, 2026 | To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled ''Golden Parachute Compensation'' and its accompanying footnotes which is included in the section of the proxy statement entitled ''The Merger-Interests of Astia's Directors and Executive Officers in the Merger,'' as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 10 funds |
| ASTRONICS CORPORATION | May 28, 2026 | To approve the adoption of the Astronics Corporation 2026 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 13 funds |
FOR 9 funds |
| ATEA PHARMACEUTICALS, INC. | June 18, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 10 funds |
| ATLAS ENERGY SOLUTIONS INC. | May 7, 2026 | Please indicate your vote, on a non-binding advisory basis, on the Company's Named Executive Officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 13 funds |
| AVADEL PHARMACEUTICALS PLC | January 12, 2026 | Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 7 funds |
| AVANOS MEDICAL,INC. | April 21, 2026 | Approval of an amendment to the Company's 2021 Long Term Incentive Plan to allow for the issuance of awards thereunder to the Company's outside directors. Compensation |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| AVEPOINT, INC. | May 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| AVIAT NETWORKS, INC. | November 5, 2025 | Advisory, non-binding vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| AVIAT NETWORKS, INC. | November 5, 2025 | Approval of Third Amended and Restated 2018 Incentive Plan of the Company. Compensation |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| AVIDITY BIOSCIENCES, INC. | February 26, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 13 funds |
| AVIDXCHANGE HOLDINGS, INC. | September 16, 2025 | To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 10 funds |
| AVNET, INC. | November 21, 2025 | Advisory vote on named executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| AVNET, INC. | November 21, 2025 | Approval of the 2025 Stock Compensation and Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| AXOGEN, INC. | June 23, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| AXSOME THERAPEUTICS, INC. | June 5, 2026 | To approve, by non-binding advisory vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| AZENTA, INC. | January 28, 2026 | To approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by 2,750,000. Compensation |
Board | For | AGAINST 5 funds |
FOR 14 funds |
| Abeona Therapeutics Inc. | June 12, 2026 | Election of three Class 1 Directors for a three-year term: Michael Amoroso Director Elections |
Board | For | FOR 1 fund |
AGAINST 5 funds |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Randy L. Newman Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 9 funds |
| Alignment Healthcare, Inc. | June 4, 2026 | Approval, on an non-binding, advisory basis, of the compensation of our Named Executive Officers Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| Alliance Laundry Holdings Inc. | June 11, 2026 | To approve, on an advisory (nonbinding) basis, the compensation of our named executive officers and Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| Angi Inc. | June 10, 2026 | Election of Class II Directors: Glenn H. Schiffman Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 5 funds |
| Arm Holdings Plc | September 9, 2025 | Elect Jeffrey A. Sine as Director Director Elections |
Board | For | FOR 8 funds |
AGAINST 11 funds |
Page 1 of 11 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.